Characterization of 5-HT(1A) receptor-mediated [35S]GTPγS binding in rat hippocampal membranes

European Journal of Pharmacology

Volumn 343, Issue 2-3, 1998, Pages 303-312

  Alper, Richard H ^a   Nelson, David L ^b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

5 HT(1A) receptor; 8 OH DPAT (8 hydroxy 2 (di n propylamino)tetralin); Functional assay; G protein; Guanosine 5' O (3 35S thiotriphosphate) binding; Hippocampus rat

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 CARBAMOYLTRYPTAMINE; BUSPIRONE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE DIPHOSPHATE; METITEPINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PARTIAL AGONIST; PROTEIN; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN AGONIST; SEROTONIN RECEPTOR AFFECTING AGENT; SPIPERONE; SULFUR 35; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN 1 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SULFUR;

ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; HIPPOCAMPUS; ISOMER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; TEMPERATURE; ANIMAL; CELL MEMBRANE; DRUG EFFECT; FRONTAL LOBE; KINETICS; METABOLISM; PROTEIN BINDING; SPRAGUE DAWLEY RAT;

ANIMALS; CELL MEMBRANE; FRONTAL LOBE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); GUANOSINE DIPHOSPHATE; HIPPOCAMPUS; KINETICS; MALE; METHIOTHEPIN; PIPERAZINES; PROTEIN BINDING; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SPIPERONE; SULFUR RADIOISOTOPES; TEMPERATURE;

EID: 0032545813     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01547-1     Document Type: Article

References (27)

1. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
2. 9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain. Eur. J. Pharmacol. 323:1997;R3-R4.
3. 4 receptors. J. Neurochem. 63:1994;62-65.
4. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
5. 1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture. Mol. Pharmacol. 33:1988;178-186.
6. i-adenylate cyclase complex in rat hippocampus. Eur. J. Pharmacol. 154:1988;95-98.
7. Hilf G., Gierschik P., Jakobs K.H. Muscarinic acetylcholine receptor-stimulated binding of guanosine 5′-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes. Eur. J. Biochem. 186:1989;725-731.
8. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46:1994;157-203.
9. Kenakin T. The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol. Rev. 48:1996;413-463.
10. Lazareno S., Farries T., Birdsall N.J. Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors m1-m4. Life Sci. 52:1993;449-456.
11. 1A 5-hydroxytryptamine receptors in Chinese hamster ovary cells. Biochem. J. 285:1992;933-938.
12. 1A receptors. Neuropharmacology. 35:1996;119-121.
13. 1A receptors Eur. J. Pharmacol. 307:1996;107-111.
14. 1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635. Br. J. Pharmacol. 120:1997;737-739.
15. 1A receptors as a function of receptor: G-protein stoichiometry. Neuropharmacology. 36:1997;451-459.
16. Northup J.K., Smigel M.D., Gilman A.G. The guanine nucleotide activating site of the regulatory component of adenylate cyclase. Identification by ligand binding. J. Biol. Chem. 257:1982;11416-11423.
17. 1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells. Biochem. Pharmacol. 45:1993;375-383.
18. 1A receptor linked to inward-rectifying potassium current in hippocampal CA3 pyramidal cells. J. Neurophysiol. 71:1994;2161-2167.
19. 1A potassium current. J. Neurophysiol. 74:1995;2189-2193.
20. 3H ]-8-OH-DPAT) Biochem. Pharmacol. 35:1986;1943-1949.
21. 1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. Br. J. Pharmacol. 95:1988;975-985.
22. Selley D.E., Sim L.J., Xiao R., Liu Q., Childers S.R. μ-Opioid receptor-stimulated guanosine-5′-O-(γ-thio)-triphosphate binding in rat thalamus and cultured cell lines: Signal transduction mechanisms underlying agonist efficacy. Mol. Pharmacol. 51:1997;87-96.
23. 35S ]GTPγS binding Eur. J. Pharmacol. 320:1997;267-275.
24. 1D receptor subtypes J. Recept. Signal Transduct. Res. 15:1995;199-211.
25. Wieland, T., Jakobs, K.H., 1994. Measurement of receptor-stimulated guanosine 5′-O-(γ-thio)triphosphate binding by G proteins. In: Iyengar, R. (Eds.), Methods in Enzymology, vol. 237: Heterotrimeric G proteins. Academic Press, San Diego, CA, pp. 3-13.
26. 1A receptors to the same effector systems in rat hippocampus: Biochemical and electrophysiological studies. Mol. Pharmacol. 35:1989;484-494.
27. Zifa E., Fillion G. 5-Hydroxytryptamine receptors. Pharmacol. Rev. 44:1992;401-458.